Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer

Next‐generation sequencing (NGS) and digital PCR technologies allow analysis of the mutational profile of circulating cell‐free DNA (cfDNA) in individuals with advanced lung cancer. We have now evaluated the feasibility of cfDNA sequencing for mutation detection in patients with non‐small cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohira, Tatsuo, Sakai, Kazuko, Matsubayashi, Jun, Kajiwara, Naohiro, Kakihana, Masatoshi, Hagiwara, Masaru, Hibi, Masaaki, Yoshida, Koichi, Maeda, Junichi, Ohtani, Keishi, Nagao, Toshitaka, Nishio, Kazuto, Ikeda, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132294/
https://www.ncbi.nlm.nih.gov/pubmed/27575703
http://dx.doi.org/10.1111/cas.13068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132294/
https://www.ncbi.nlm.nih.gov/pubmed/27575703
http://dx.doi.org/10.1111/cas.13068

Ejemplares similares